NYSEAMERICAN:INFU - InfuSystem Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$3.20 -0.10 (-3.03 %)
(As of 07/20/2018 04:00 PM ET)
Previous Close$3.30
Today's Range$3.15 - $3.30
52-Week Range$1.70 - $3.60
Volume76,400 shs
Average Volume40,789 shs
Market Capitalization$53.53 million
P/E RatioN/A
Dividend YieldN/A
Beta0.15
InfuSystem Holdings Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole mounted and ambulatory infusion pumps; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. InfuSystem Holdings Inc. was founded in 2005 and is headquartered in Madison Heights, Michigan.

Receive INFU News and Ratings via Email

Sign-up to receive the latest news and ratings for INFU and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
SymbolNYSEAMERICAN:INFU
CUSIPN/A
Phone+1-248-2911210

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-0.73%
Return on Equity-1.06%
Return on Assets-0.59%

Miscellaneous

EmployeesN/A
Outstanding Shares22,740,000
Market Cap$53.53

InfuSystem (NYSEAMERICAN:INFU) Frequently Asked Questions

What is InfuSystem's stock symbol?

InfuSystem trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU."

How will InfuSystem's stock buyback program work?

InfuSystem announced that its board has authorized a share repurchase plan on Tuesday, March 13th 2018, which permits the company to buyback 1,000,000 shares, according to EventVestor. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Shares buyback plans are often a sign that the company's board believes its stock is undervalued.

How were InfuSystem's earnings last quarter?

InfuSystem Holdings Inc (NYSEAMERICAN:INFU) posted its quarterly earnings data on Tuesday, April, 24th. The medical instruments supplier reported $0.01 earnings per share (EPS) for the quarter. The medical instruments supplier earned $16.48 million during the quarter. InfuSystem had a negative return on equity of 1.06% and a negative net margin of 0.73%. View InfuSystem's Earnings History.

What is the consensus analysts' recommendation for InfuSystem?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InfuSystem in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Who are some of InfuSystem's key competitors?

Who are InfuSystem's key executives?

InfuSystem's management team includes the folowing people:
  • Mr. Richard A. DiIorio, Pres, CEO & Director (Age 43)
  • Ms. Janet Skonieczny, Consultant (Age 58)
  • Mr. Christopher S. Downs, Former Exec. VP, Interim CFO & Member of Office of the Pres (Age 39)
  • Mr. Gregory Schulte, Exec. VP & CFO (Age 51)
  • Mr. Tom Ruiz, Sr. VP of Sales & Marketing

Has InfuSystem been receiving favorable news coverage?

Media stories about INFU stock have been trending somewhat positive on Saturday, according to Accern Sentiment Analysis. The research firm rates the sentiment of media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. InfuSystem earned a news impact score of 0.22 on Accern's scale. They also gave media coverage about the medical instruments supplier an impact score of 45.56 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

Who are InfuSystem's major shareholders?

InfuSystem's stock is owned by a number of of retail and institutional investors. Top institutional investors include MORRIS RYAN J. (5.50%). Company insiders that own InfuSystem stock include Christopher Downs, Christopher R Sansone, Darrell B Montgomery, David C Dreyer, Eric K Steen, Gregg Owen Lehman, Meridian Ohc Partners, Lp, Richard Dilorio and Ryan J Morris. View Institutional Ownership Trends for InfuSystem.

How do I buy shares of InfuSystem?

Shares of INFU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is InfuSystem's stock price today?

One share of INFU stock can currently be purchased for approximately $3.20.

How big of a company is InfuSystem?

InfuSystem has a market capitalization of $53.53 million.

How can I contact InfuSystem?

InfuSystem's mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The medical instruments supplier can be reached via phone at +1-248-2911210.


MarketBeat Community Rating for InfuSystem (NYSEAMERICAN INFU)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  60 (Vote Outperform)
Underperform Votes:  61 (Vote Underperform)
Total Votes:  121
MarketBeat's community ratings are surveys of what our community members think about InfuSystem and other stocks. Vote "Outperform" if you believe INFU will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INFU will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.